Clinical trial
Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults &…
NCT02281357 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT02281357 |
|---|---|
| Title | Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma |
| Official title | A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid Use in Adults and Adolescents With Oral Corticosteroid Dependent Asthma (TROPOS) |
| Acronym | TROPOS |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Biological, Other |
| Interventions | Tralokinumab, Placebo |
| Enrollment | 140 |
| Start date | Feb 19, 2015 |
| Primary completion | Sep 7, 2017 |
| Completion | Sep 7, 2017 |
| First posted | Nov 3, 2014 |
| Last update posted | Mar 15, 2019 |
| Countries | Belgium, France, Germany, Netherlands, Poland, Ukraine, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: